Harvard Bioscience Inc (HBIO) Insider Ownership

Based on data from the past 90 days ending February 07, 2026, Harvard Bioscience's three largest insider shareholders are Director James W Green (2.45Mn shares), Chief Executive Officer John D Duke (1.00Mn shares), Director Katherine A. Eade (421.13K shares).

• Harvard Bioscience Inc (HBIO) exhibits a conventional ownership structure with institutions commanding 40.52% of outstanding shares, insider ownership remaining at 14.38%, and public/other investors holding 45.10%.
• As of February 07, 2026, insider ownership at Harvard Bioscience represents 14.38% of the company's total outstanding shares, comprising approximately 5.90Mn shares out of 41.03Mn outstanding shares.
• Harvard Bioscience's insider ownership increased by 21.58% during the 90-day period ending February 07, 2026, with total insider holdings growing from 4.85Mn shares to 5.90Mn shares.
• As of February 07, 2026, Director William Snider emerged as Harvard Bioscience's top insider buyer over the preceding 90 days, securing 110.00K shares.
• Harvard Bioscience had no significant insider sales in the last 90 days.